Cubist Pharmaceuticals Inc (CBST), Trius Therapeutics, Inc. (TSRX): This Week in Biotech
With the SPDR S&P Biotech Index up 43% over the trailing-12-month period, it's evident that investment dollars are willingly flowing into the biotech sector.
Cubist Pharmaceuticals Inc (CBST)
Market is closed
News
- First
- << Previous
- 11 - 20
- Next >>
Cubist Pharmaceuticals Inc (CBST), Optimer Pharmaceuticals, Inc. (OPTR), Trius Therapeutics, Inc. (TSRX): Will This Biotech Company’s Big Bet Pay Off?
Cubist Pharmaceuticals Inc (NASDAQ:CBST) surged 10% on July 31, after the company acquired two antibiotic makers, Optimer Pharmaceuticals, Inc. (NASDAQ:OPTR) and Trius Therapeutics, Inc.
Anatomy of an Earnings Jump: Cubist Pharmaceuticals Inc (CBST)
Shares of Cubist Pharmaceuticals Inc (NASDAQ:CBST) exploded upward on Friday, finishing up over 9%.
Taro Pharmaceutical Industries Ltd. (TARO): Insiders Aren't Crazy About It
Taro Pharmaceutical Industries Ltd. (NYSE:TARO) was in 8 hedge funds' portfolio at the end of March. TARO investors should pay attention to an increase in enthusiasm from smart money in recent months.
Merck & Co., Inc. (MRK): Don’t Invest in Biotech IPOs Until You Read This
A spate of 10 biotechs went public this year, raising over $725 million.
Is United Therapeutics Corporation (UTHR) Going to Burn These Hedge Funds?
If you'd ask most investors, hedge funds are perceived as slow, old investment tools of the past.
Here is What Hedge Funds Think About Cubist Pharmaceuticals Inc (CBST)
Cubist Pharmaceuticals Inc (NASDAQ:CBST) was in 22 hedge funds' portfolio at the end of March. CBST investors should pay attention to an increase in hedge fund interest of late.
Should You Buy The Medicines Company (MDCO)?
At the moment, there are a multitude of metrics investors can use to analyze their holdings. A duo of the most under-the-radar are hedge fund and insider trading activity.
The Medicines Company (MDCO): Is There a Future for Small Pharma?
Small pharma is fighting an uphill battle. Fortunately, this is precisely what inspires a lot of companies to reach for the heavens.
AstraZeneca plc (ADR) (AZN): The Latest News
AstraZeneca plc (ADR) (NYSE:AZN)'s in a tight spot.
- First
- << Previous
- 11 - 20
- Next >>
Billionaire Hedge Funds
